ISTH 2021 Congress
Hemophilia and Rare Bleeding Disorders » Management of Bleeding and Trauma
Theme Navigation
- ISTH 2021 Congress
- Hemophilia and Rare Bleeding Disorders
- Management of Bleeding and Trauma
- Hemophilia and Rare Bleeding Disorders
-
Abstract Number: OC 26.2
Cryoprecipitate, and Not Fibrinogen Concentrate, Enhances Early Clot Formation in an in vitro Microfluidic Model of Dilutional Coagulopathy
-
Abstract Number: PB0673
Decreased Annual Bleeding Rate in Paediatric Patients with Hemophilia a and Inhibitors Treated with Emicizumab vs Bypassing Agents Experience at the National Institute of Pediatrics, Mexico City, Mexico
-
Abstract Number: OC 07.4
Detection of Joint Effusions in Pediatric Patients with Hemophilia Using Artificial Intelligence-assisted Ultrasound Scanning; Early Insights from the Development of a Self-management Tool
-
Abstract Number: PB0667
Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as measured by Whole Blood Thromboelastographic Analysis
-
Abstract Number: LPB0068
Efficacy of Parenteral Formulations of Desmopressin in the Treatment of Bleeding Disorders: A Systematic Review
-
Abstract Number: OC 38.4
Elimination of Factor VIII Inhibitors by the IgG-degrading Enzyme of Streptococcus pyogenes
-
Abstract Number: PB0671
Extended Half-life Products for Perioperative Hemostasis in Major Orthopedic Surgery: Real-world Data from the LASH Study
-
Abstract Number: PB0666
Functional Transitory Anti-emicizumab Antibody Creating Bleeding Episodes
-
Abstract Number: PB0668
Global Octim® Shortage: Experience in Strasbourg
-
Abstract Number: PB0672
Late Prophylaxis in Severe Hemophilia A: Effect on Functional Abilities
-
Abstract Number: PB0665
Off-label Use of Emicizumab in Persons with Acquired Hemophilia A and von Willebrand Disease: A Scoping Review of the Literature
-
Abstract Number: OC 26.4
Plasmin-responsive Procoagulant Synthetic Platelets for Fibrin Clot Stabilization in Hemorrhage Control
-
Abstract Number: LPB0069
Self-Propelled Hemostatic Powder Safely Achieves and Maintains Hemostasis in a Live Porcine Model of Upper Gastrointestinal Bleeding